CRWD · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▼ P/S 47.5 — expensive for this stock (over 4 y: from 11.0 to 24.6)
• ▼ FCF yield 0.5% — expensive for this stock (over 7 y: from 0.2% to 2.7%)
• ▼ FCF yield 0.5% vs peer median 1.0% — more expensive than peers
• ▲ Forward P/E 155.4 is below the current one — earnings growth expected

• ▼ Share count up 7% in 3 y — your stake is being diluted
• ▼ Operating loss — nothing covers the interest
• ▼ ROE 1% — weak return on equity
• ▲ Net margin rose: -8.2% → -3.4%
• ▲ Debt / equity 0.19 — moderate debt
• ▲ Free cash flow positive every year

• ▲ Revenue grows 29.0% per year (3 y)
• ▼ Analysts cut the earnings forecast by -1.9% in 90 days

• ▲ Over 6 mo stronger than its sector (XLK) by 112%
• ▲ Price above SMA200 — long-term uptrend
• ▲ SMA50 above SMA200 — trend up
• ▲ Over a year +86% vs S&P 500 +11% — stronger than the market

• ▼ Volatility 56% per year — much higher than the market (13%)
• ▼ Max drawdown in the period -68% — deep

• ▲ Consensus of 50 analysts — buy
• ▼ Insiders selling over 6 mo

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▲ Sector (XLK) above SMA200 — in an uptrend